141 related articles for article (PubMed ID: 19818510)
1. APP expression, distribution and accumulation are altered by aluminum in a rodent model for Alzheimer's disease.
Walton JR; Wang MX
J Inorg Biochem; 2009 Nov; 103(11):1548-54. PubMed ID: 19818510
[TBL] [Abstract][Full Text] [Related]
2. Brain lesions comprised of aluminum-rich cells that lack microtubules may be associated with the cognitive deficit of Alzheimer's disease.
Walton JR
Neurotoxicology; 2009 Nov; 30(6):1059-69. PubMed ID: 19591863
[TBL] [Abstract][Full Text] [Related]
3. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration.
Walton JR
J Inorg Biochem; 2007 Sep; 101(9):1275-84. PubMed ID: 17662457
[TBL] [Abstract][Full Text] [Related]
4. A longitudinal study of rats chronically exposed to aluminum at human dietary levels.
Walton JR
Neurosci Lett; 2007 Jan; 412(1):29-33. PubMed ID: 17156917
[TBL] [Abstract][Full Text] [Related]
5. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
6. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease.
Van Broeck B; Vanhoutte G; Pirici D; Van Dam D; Wils H; Cuijt I; Vennekens K; Zabielski M; Michalik A; Theuns J; De Deyn PP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S
Neurobiol Aging; 2008 Feb; 29(2):241-52. PubMed ID: 17112635
[TBL] [Abstract][Full Text] [Related]
7. Age and damage induced changes in amyloid protein precursor immunohistochemistry in the rat brain.
Beeson JG; Shelton ER; Chan HW; Gage FH
J Comp Neurol; 1994 Apr; 342(1):69-77. PubMed ID: 8207128
[TBL] [Abstract][Full Text] [Related]
8. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein.
Lee KW; Lee SH; Kim H; Song JS; Yang SD; Paik SG; Han PL
J Neurosci Res; 2004 May; 76(4):572-80. PubMed ID: 15114629
[TBL] [Abstract][Full Text] [Related]
9. Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing.
Kumar VB; Franko M; Banks WA; Kasinadhuni P; Farr SA; Vyas K; Choudhuri V; Morley JE
J Exp Biol; 2009 Feb; 212(Pt 4):494-8. PubMed ID: 19181896
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
[TBL] [Abstract][Full Text] [Related]
11. Genetic background regulates beta-amyloid precursor protein processing and beta-amyloid deposition in the mouse.
Lehman EJ; Kulnane LS; Gao Y; Petriello MC; Pimpis KM; Younkin L; Dolios G; Wang R; Younkin SG; Lamb BT
Hum Mol Genet; 2003 Nov; 12(22):2949-56. PubMed ID: 14506131
[TBL] [Abstract][Full Text] [Related]
12. Cognitive and physical activity differently modulate disease progression in the amyloid precursor protein (APP)-23 model of Alzheimer's disease.
Wolf SA; Kronenberg G; Lehmann K; Blankenship A; Overall R; Staufenbiel M; Kempermann G
Biol Psychiatry; 2006 Dec; 60(12):1314-23. PubMed ID: 16806094
[TBL] [Abstract][Full Text] [Related]
13. Functional impairment in aged rats chronically exposed to human range dietary aluminum equivalents.
Walton JR
Neurotoxicology; 2009 Mar; 30(2):182-93. PubMed ID: 19109991
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease.
Wu ZL; Ciallella JR; Flood DG; O'Kane TM; Bozyczko-Coyne D; Savage MJ
Neurobiol Aging; 2006 Mar; 27(3):377-86. PubMed ID: 15927307
[TBL] [Abstract][Full Text] [Related]
15. Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension.
McKinnon SJ; Lehman DM; Kerrigan-Baumrind LA; Merges CA; Pease ME; Kerrigan DF; Ransom NL; Tahzib NG; Reitsamer HA; Levkovitch-Verbin H; Quigley HA; Zack DJ
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1077-87. PubMed ID: 11923249
[TBL] [Abstract][Full Text] [Related]
16. APP gene family: unique age-associated changes in splicing of Alzheimer's betaA4-amyloid protein precursor.
Sandbrink R; Masters CL; Beyreuther K
Neurobiol Dis; 1994 Nov; 1(1-2):13-24. PubMed ID: 9216982
[TBL] [Abstract][Full Text] [Related]
17. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
[TBL] [Abstract][Full Text] [Related]
18. Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formation.
Heikkinen T; Kalesnykas G; Rissanen A; Tapiola T; Iivonen S; Wang J; Chaudhuri J; Tanila H; Miettinen R; Puoliväli J
Exp Neurol; 2004 May; 187(1):105-17. PubMed ID: 15081593
[TBL] [Abstract][Full Text] [Related]
19. Amyloid precursor protein: from synaptic plasticity to Alzheimer's disease.
Mileusnic R; Lancashire CL; Rose SP
Ann N Y Acad Sci; 2005 Jun; 1048():149-65. PubMed ID: 16154929
[TBL] [Abstract][Full Text] [Related]
20. [The role of immobilization stress and sertindole on the expression of APP, MAPK-1 and beta-actin genes in rat brain].
Kállmán J; Pákáski M; Szucs S; Kálmán S; Fazekas O; Santha P; Szabó G; Janka Z; Kálmán J
Ideggyogy Sz; 2012 Nov; 65(11-12):394-400. PubMed ID: 23289174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]